WO2003099006A1 - Disinfectant with activity against hepatitis b virus - Google Patents

Disinfectant with activity against hepatitis b virus Download PDF

Info

Publication number
WO2003099006A1
WO2003099006A1 PCT/IB2003/001137 IB0301137W WO03099006A1 WO 2003099006 A1 WO2003099006 A1 WO 2003099006A1 IB 0301137 W IB0301137 W IB 0301137W WO 03099006 A1 WO03099006 A1 WO 03099006A1
Authority
WO
WIPO (PCT)
Prior art keywords
weight
disinfectant
acid
quaternary ammonium
ammonium compound
Prior art date
Application number
PCT/IB2003/001137
Other languages
French (fr)
Inventor
Peter Goroncy-Bermes
Michael Mohr
Original Assignee
Air Liquide Sante (International)
Schulke & Mayr
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Family has litigation
First worldwide family litigation filed litigation Critical https://patents.darts-ip.com/?family=29557389&utm_source=google_patent&utm_medium=platform_link&utm_campaign=public_patent_search&patent=WO2003099006(A1) "Global patent litigation dataset” by Darts-ip is licensed under a Creative Commons Attribution 4.0 International License.
Application filed by Air Liquide Sante (International), Schulke & Mayr filed Critical Air Liquide Sante (International)
Priority to AU2003215806A priority Critical patent/AU2003215806A1/en
Priority to EP03755238.7A priority patent/EP1511381B1/en
Priority to JP2004506543A priority patent/JP4505323B2/en
Priority to ES03755238T priority patent/ES2432545T3/en
Priority to US10/515,258 priority patent/US20050215639A1/en
Publication of WO2003099006A1 publication Critical patent/WO2003099006A1/en

Links

Classifications

    • AHUMAN NECESSITIES
    • A01AGRICULTURE; FORESTRY; ANIMAL HUSBANDRY; HUNTING; TRAPPING; FISHING
    • A01NPRESERVATION OF BODIES OF HUMANS OR ANIMALS OR PLANTS OR PARTS THEREOF; BIOCIDES, e.g. AS DISINFECTANTS, AS PESTICIDES OR AS HERBICIDES; PEST REPELLANTS OR ATTRACTANTS; PLANT GROWTH REGULATORS
    • A01N33/00Biocides, pest repellants or attractants, or plant growth regulators containing organic nitrogen compounds
    • A01N33/02Amines; Quaternary ammonium compounds
    • A01N33/04Nitrogen directly attached to aliphatic or cycloaliphatic carbon atoms
    • AHUMAN NECESSITIES
    • A01AGRICULTURE; FORESTRY; ANIMAL HUSBANDRY; HUNTING; TRAPPING; FISHING
    • A01NPRESERVATION OF BODIES OF HUMANS OR ANIMALS OR PLANTS OR PARTS THEREOF; BIOCIDES, e.g. AS DISINFECTANTS, AS PESTICIDES OR AS HERBICIDES; PEST REPELLANTS OR ATTRACTANTS; PLANT GROWTH REGULATORS
    • A01N37/00Biocides, pest repellants or attractants, or plant growth regulators containing organic compounds containing a carbon atom having three bonds to hetero atoms with at the most two bonds to halogen, e.g. carboxylic acids
    • A01N37/12Biocides, pest repellants or attractants, or plant growth regulators containing organic compounds containing a carbon atom having three bonds to hetero atoms with at the most two bonds to halogen, e.g. carboxylic acids containing the group, wherein Cn means a carbon skeleton not containing a ring; Thio analogues thereof
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61PSPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P31/00Antiinfectives, i.e. antibiotics, antiseptics, chemotherapeutics
    • A61P31/02Local antiseptics
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61PSPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P31/00Antiinfectives, i.e. antibiotics, antiseptics, chemotherapeutics
    • A61P31/12Antivirals
    • A61P31/20Antivirals for DNA viruses

Definitions

  • the invention relates to disinfectants and to the use thereof for inactivating hepatitis B virus.
  • short-chain organic acids such as formic acid, acetic acid, citric acid.
  • Aldehydes such as formaldehyde, acetaldehyde and glutaraldehyde .
  • Aldehyde-containing products show excellent activity against HBV.
  • aldehyde-containing disinfectants have been unwanted for some years because of the harmful effects on human health, especially of formalin.
  • the object on which the present invention was based was to provide disinfectants which
  • the proposal according to the invention for the inactivation of HBV is a water-based disinfectant which comprises a) at least one alkylamine and/or at least one quaternary ammonium compound and
  • quaternary ammonium compounds (quats) and alkylamines which can be used according to the invention are benzalkonium chloride, didecyldimethyl- ammonium chloride and dioctyldimethylammonium chloride, and bis (3-aminopropyl) octylamine, aminopropyldodecyl- amine, dodecylpropylenediamine, coconut fatty amine 2EO and dimethyl coconut fatty amine. It is possible to employ quat mixtures, amine mixtures and also mixtures of quat(s) and amine (s) . A mixture of dioctyldimethylammonium chloride with bis (3-aminopropyl) octylamine is particularly preferred.
  • Disinfectants which have proved to be particularly effective comprise from 1 to 40% by weight, preferably 3 to 25% by weight, in particular 5 to 20% by weight, of alkylamine and/or quaternary ammonium compound, based on the disinfectant.
  • the group R of the fatty acid is preferably saturated or unsaturated, unbranched or branched, unsubstituted or substituted C 9 - to C 25 -alkyl, preferably C ⁇ 2 - to C 23 - alkyl.
  • R is particularly preferably monounsaturated C ⁇ 3 - to C 2 ⁇ -alkyl, e.g. RCOOH is oleic acid.
  • fatty acids and their salts are partly dissociated when present in aqueous solutions.
  • Salts of the fatty acids are preferably employed to formulate the disinfectants employed according to the invention, such as alkali metal or ammonium salts, in particular sodium salts, for example sodium oleate.
  • the content of component b) is preferably from 0.05 to 5% by weight, in particular 0.1 to 3% by weight, such as 0.5 to 2% by weight, based on the disinfectant (calculated as free acid RCOOH) .
  • the disinfectant comprises from 5 to 20% by weight of quaternary ammonium compound and/or alkylamine and from 0.5 to 2% by weight of sodium oleate .
  • the disinfectant used according to the invention additionally comprises where appropriate one or more other substances such as nonionic surfactants, short-chain organic acids such as lactic acid, glycolic acid, citric acid, malic acid, succinic acid, tartaric acid, formic acid, acetic acid, propionic acid or salts thereof, corrosion inhibitors, perfume, dye and alcohols.
  • the short-chain organic acids are employed in particular for adjusting the amine formulations to the preferred pH of from 9.0 to 9.5. In the case of quat formulations, where appropriate adjustment to the desired pH of from 9.0 to 9.5 is necessary with basifying substances.
  • N, N, N' , N' -tetrakis (2-hydroxypropyl) ethylenediamine is particularly suitable.
  • the content of every single one of the other substances is preferably up to 5% by weight .
  • a preferred alcohol is isopropanol. It is also possible to employ in addition or in place of isopropanol other alcohols such as ethanol or n-propanol or glycols or aromatic alcohols such as phenoxypropanols, which act as solubilizers to stabilize the concentrate.
  • the alcohols prevent crystallization, improve the low- temperature stability and serve as further active ingredients; their concentration can also be distinctly higher than 5% by weight and be, for example, from 10 to 50% by weight, such as 20 to 40% by weight.
  • the disinfectant displays as 2% by weight aqueous solution a foaming power of less than 45 ml, preferably less than 42 ml, in particular less than 39 ml or even 37 ml or less, determined by the following method:
  • the invention further relates to the use of the disinfectant for disinfecting surfaces and instruments.
  • Surfaces are generally disinfected by scouring or wiping methods.
  • Instruments are disinfected by manual insertion of the instruments or by mechanical methods in automatic processors.
  • a ready-to-use solution which represents an aqueous solution of the disinfectant and comprises from 0.3 to 10% by weight, preferably 0.5 to 5% by weight, in particular 1 to 3 % by weight, e.g. 2% by weight, of the disinfectant.
  • Thermochemical disinfection of instruments is carried out in special automatic cleaning and disinfection systems.
  • An example of a program flow in which the disinfectant according to the invention can be employed advantageously in the form of an instrument disinfectant is as follows:
  • thermochemical disinfection the three parameters of concentration, exposure time and temperature are chosen suitably by the skilled person.
  • Particularly preferred disinfectants contain the following components in the following quantities:
  • Bardac LF dioctydimethylammonium chloride (50% strength) ,
  • Lonzabac LF bis (3-aminopropyl) octylamine and nonionic surfactant: alkylpolyoxylakylene glycol ether (low-foaming surfactant) .
  • hepatitis B surface antigen HBsAG
  • the formulations were in each case diluted with sterile double-distilled water to the desired concentrations (1% by weight, 2% by weight and 3% by weight) immediately before the inactivation tests.
  • the disinfectant tests took place in a suspension test at room temperature, with the volume ratios and the protein loading being carried out in accordance with the guideline of the German health agency (BGA) and the German association for controlling viral diseases (DVV) on the testing of the activity of chemical disinfectants against viruses, see Bundes Rheins- blatt 25, 1982, pages 397-8.
  • the test mixture consisted of one part of an HBsAg-containing serum (HBsAg and HBeAg pos .
  • test mixture containing double-distilled water in place of the disinfectant was investigated for HBsAg after the longest of the tested exposure times. This mixture, which was also carried out with serum albumin and FCS, represented the initial values for calculating the increase in HBsAg.
  • serum albumin and FCS represented the initial values for calculating the increase in HBsAg.
  • a 100 ml measuring cylinder (high form with graduation and lettering) with a fitting stopper and a stop-clock are required.
  • 30 ml of the formulation solution to be tested are introduced into the measuring cylinder, avoiding foaming as far as possible (if foam has formed on introduction of the formulation solution, the test is not carried out until - li the foam has disappeared.)
  • the stopper is then put on.
  • the measuring cylinder is shaken vigorously ten times and then put down, starting the stop-clock simultaneously.
  • the height of the foam in the measuring cylinder (volume of the sample including foam) is then read off after predetermined times.
  • the results of the investigation are recorded, stating the sample temperature .
  • Formulation IB was investigated as 1.0% strength, 2.0% strength and 3.0% strength solution in the inactivation tests. The exposure times were 5, 15 and 30 minutes. The results are shown in Tables 1-3 below.
  • Table 1 Hepatitis B-inactivating properties of formulation IB (1.0%) in the antigen assay. The cpm are shown.
  • Table 3 Hepatitis B-inactivating properties of formulation IB (3.0%) in the antigen assay. The cpm are shown.
  • Formulation IB showed a strong effect on the immunological reactivity of HBsAg. However, in the investigation of the 1% strength solution, counts above the lower limit of detection were not seen until after an exposure time of 30 minutes (see Table 1) . The 2% strength dilution of the disinfectant in particular showed HBV activity (see Table 2) . It can be stated as a result that a 2% strength solution of formulation IB can be employed for HBV inactivation on use for 15 minutes as surface disinfectant.
  • Exemplary formulation IB shows that the activity of quaternary ammonium compounds against HBV is increased through use of 1% by weight fatty acid salt (sodium oleate) . It was also possible to reduce the total amount of active ingredients.
  • Formulations 2A and 2B were tested for their HBV activity correspondingly. The results are shown in Table 4 below. Table 4: HBV activity of formulations based on quaternary ammonium compound
  • Table 5 HBV activity of formulations based on alkylamine (at 55°C)
  • the formulations solutions were 2% strength solutions in tap water at 22°C.
  • Formulation 4A showed foam suppression Formulation 4B showed foam suppression Formulation 4C showed no foam suppression

Landscapes

  • Life Sciences & Earth Sciences (AREA)
  • Health & Medical Sciences (AREA)
  • General Health & Medical Sciences (AREA)
  • Engineering & Computer Science (AREA)
  • Agronomy & Crop Science (AREA)
  • Pest Control & Pesticides (AREA)
  • Plant Pathology (AREA)
  • Dentistry (AREA)
  • Wood Science & Technology (AREA)
  • Zoology (AREA)
  • Environmental Sciences (AREA)
  • Communicable Diseases (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Virology (AREA)
  • Veterinary Medicine (AREA)
  • Oncology (AREA)
  • Chemical & Material Sciences (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • General Chemical & Material Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • Public Health (AREA)
  • Organic Chemistry (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Animal Behavior & Ethology (AREA)
  • Molecular Biology (AREA)
  • Biotechnology (AREA)
  • Agricultural Chemicals And Associated Chemicals (AREA)
  • Acyclic And Carbocyclic Compounds In Medicinal Compositions (AREA)
  • Medicinal Preparation (AREA)

Abstract

Water-based disinfectant which comprises (a) at least one alkylamine and/or at least one quaternary ammonium compound and (b) at least one tatty acid RCOOH and/or salt thereof, where R is a group having at least 7 carbon atoms, and use of the disinfectant for inactivating hepatitis B virus.

Description

Disinfectant with activity against hepatitis B virus
The invention relates to disinfectants and to the use thereof for inactivating hepatitis B virus.
Three groups of substances have been used to date in particular for the inactivation of viruses such as hepatitis B virus using surface (skin, floor) and instrument disinfectants:
short-chain organic acids such as formic acid, acetic acid, citric acid.
The effect of such monobasic or polybasic acids is disclosed inter alia in EP-A-0 505 763 and AT-A 3823190, see also Hygiene + Medizin 1989, 14, pages 69 et seq., GB-A-2 103 089 and Tierarztliche Umschau 1988, 43, pages 646 et seq. However, a disadvantage which has emerged is that such disinfectants inevitably have a low pH and accordingly have a strong corrosive action especially when used at elevated temperatures for disinfecting instruments.
- Quaternary ammonium compounds.
These have proved to be, especially in disinfectants with a very high alcohol content, e.g. in anhydrous isopropanol/n-propanol or 80% ethanol, effective disinfectants for the hands (see, inter alia, allhauser, Praxis der Sterilisation, Henkel Chemische Bibliothek, 4th edition, 1988, pages 75 et seq.). However, tests by the Applicant have shown that quaternary ammonium compounds are not reliably effective for HBV in solutions with very low alcohol content. On the other hand, disinfectants with high alcohol concentrations are unsuitable inter alia for disinfecting instruments because they attack plastic materials. In addition, disinfectants containing quaternary ammonium compounds are high- foaming, which restricts their use, especially for disinfecting instruments.
Aldehydes such as formaldehyde, acetaldehyde and glutaraldehyde .
Aldehyde-containing products show excellent activity against HBV. However, aldehyde-containing disinfectants have been unwanted for some years because of the harmful effects on human health, especially of formalin.
Accordingly, the object on which the present invention was based was to provide disinfectants which
1. for reasons of cost and for good tolerability on possible contact of the user with the disinfectant are low in active ingredient and well tolerated (non-irritant) for people,
2. are not inevitably strongly acidic and corrosive,
3. have no foaming action,
4. can be formulated with low alcohol content,
5. do note inevitably require the presence of aldehyde,
6. are compatible with other optional ingredients and
7. inactivate hepatitis B virus outstandingly even used in low concentration.
The proposal according to the invention for the inactivation of HBV is a water-based disinfectant which comprises a) at least one alkylamine and/or at least one quaternary ammonium compound and
b) at least one fatty acid RCOOH and/or salt thereof, where R is a group having at least 7 carbon atoms.
Examples of quaternary ammonium compounds (quats) and alkylamines which can be used according to the invention are benzalkonium chloride, didecyldimethyl- ammonium chloride and dioctyldimethylammonium chloride, and bis (3-aminopropyl) octylamine, aminopropyldodecyl- amine, dodecylpropylenediamine, coconut fatty amine 2EO and dimethyl coconut fatty amine. It is possible to employ quat mixtures, amine mixtures and also mixtures of quat(s) and amine (s) . A mixture of dioctyldimethylammonium chloride with bis (3-aminopropyl) octylamine is particularly preferred.
Disinfectants which have proved to be particularly effective comprise from 1 to 40% by weight, preferably 3 to 25% by weight, in particular 5 to 20% by weight, of alkylamine and/or quaternary ammonium compound, based on the disinfectant.
In a disinfectant according to the invention, the group R of the fatty acid is preferably saturated or unsaturated, unbranched or branched, unsubstituted or substituted C9- to C25-alkyl, preferably Cι2- to C23- alkyl. R is particularly preferably monounsaturated Cι3- to C2ι-alkyl, e.g. RCOOH is oleic acid.
The skilled person is aware that fatty acids and their salts are partly dissociated when present in aqueous solutions. Salts of the fatty acids are preferably employed to formulate the disinfectants employed according to the invention, such as alkali metal or ammonium salts, in particular sodium salts, for example sodium oleate. The content of component b) is preferably from 0.05 to 5% by weight, in particular 0.1 to 3% by weight, such as 0.5 to 2% by weight, based on the disinfectant (calculated as free acid RCOOH) . In a particularly preferred embodiment, the disinfectant comprises from 5 to 20% by weight of quaternary ammonium compound and/or alkylamine and from 0.5 to 2% by weight of sodium oleate .
Besides the components which are stipulated as obligatory according to the invention, the disinfectant used according to the invention additionally comprises where appropriate one or more other substances such as nonionic surfactants, short-chain organic acids such as lactic acid, glycolic acid, citric acid, malic acid, succinic acid, tartaric acid, formic acid, acetic acid, propionic acid or salts thereof, corrosion inhibitors, perfume, dye and alcohols. The short-chain organic acids are employed in particular for adjusting the amine formulations to the preferred pH of from 9.0 to 9.5. In the case of quat formulations, where appropriate adjustment to the desired pH of from 9.0 to 9.5 is necessary with basifying substances. This is possible for example with sodium hydroxide solution, but N, N, N' , N' -tetrakis (2-hydroxypropyl) ethylenediamine is particularly suitable. The content of every single one of the other substances is preferably up to 5% by weight .
A preferred alcohol is isopropanol. It is also possible to employ in addition or in place of isopropanol other alcohols such as ethanol or n-propanol or glycols or aromatic alcohols such as phenoxypropanols, which act as solubilizers to stabilize the concentrate. The alcohols prevent crystallization, improve the low- temperature stability and serve as further active ingredients; their concentration can also be distinctly higher than 5% by weight and be, for example, from 10 to 50% by weight, such as 20 to 40% by weight.
In a particularly preferred embodiment, the disinfectant displays as 2% by weight aqueous solution a foaming power of less than 45 ml, preferably less than 42 ml, in particular less than 39 ml or even 37 ml or less, determined by the following method:
1. foam-free introduction of 30 ml of solution into a 100 ml measuring cylinder at 20 to 25°C,
2. placing of a stopper on the measuring cylinder,
3. vigorous shaking ten times and
4. after the end of the shaking immediate determination of the height of the foam, stated as volume of the solution including foam.
The invention further relates to the use of the disinfectant for disinfecting surfaces and instruments. Surfaces are generally disinfected by scouring or wiping methods. Instruments are disinfected by manual insertion of the instruments or by mechanical methods in automatic processors. Typically employed in the said method is a ready-to-use solution which represents an aqueous solution of the disinfectant and comprises from 0.3 to 10% by weight, preferably 0.5 to 5% by weight, in particular 1 to 3 % by weight, e.g. 2% by weight, of the disinfectant.
Thermochemical disinfection of instruments, especially temperature-sensitive instruments such as flexible endoscopes, is carried out in special automatic cleaning and disinfection systems. An example of a program flow in which the disinfectant according to the invention can be employed advantageously in the form of an instrument disinfectant is as follows:
1. where appropriate precleaning with cold water, 2. cleaning at 55 to 60°C with a neutral cleaner (e.g. as 0.5% strength solution),
3. thermochemical disinfection at 55 to 60°C and an exposure time of from 1 to 20 minutes, e.g. about 5 minutes, to a disinfectant according to the invention (e.g. 1 to 3% strength),
rinsing with cold water and
5. drying.
For thermochemical disinfection, the three parameters of concentration, exposure time and temperature are chosen suitably by the skilled person. Particularly preferred disinfectants contain the following components in the following quantities:
(i) Surface disinfectant (data in % by weight)
Figure imgf000007_0001
[ii) Instrument disinfectant (data in percent by weight)
Figure imgf000008_0001
The advantages of the invention are evident in particular from the following examples. Unless stated otherwise, all percentage data in the examples are based on weight.
Examples
The following substances were used:
Bardac LF: dioctydimethylammonium chloride (50% strength) ,
Lonzabac LF: bis (3-aminopropyl) octylamine and nonionic surfactant: alkylpolyoxylakylene glycol ether (low-foaming surfactant) .
Formulations based on quaternary ammonium compound
Figure imgf000008_0002
Formulations based on alkylamine
Figure imgf000009_0001
Investigation of the HBV activity of formulations
For the investigations with the formulations, the destruction of the antigenicity of the surface antigen (hepatitis B surface antigen = HBsAG) was used as indirect marker of hepatitis B activity. The formulations were in each case diluted with sterile double-distilled water to the desired concentrations (1% by weight, 2% by weight and 3% by weight) immediately before the inactivation tests.
The disinfectant tests took place in a suspension test at room temperature, with the volume ratios and the protein loading being carried out in accordance with the guideline of the German health agency (BGA) and the German association for controlling viral diseases (DVV) on the testing of the activity of chemical disinfectants against viruses, see Bundesgesundheits- blatt 25, 1982, pages 397-8. The test mixture consisted of one part of an HBsAg-containing serum (HBsAg and HBeAg pos . , DNA polymerase detectable, HBV PCR pos., virus genomes > 108/ml) , one part of double-distilled water or one part of a 2% strength serum albumin solution or one part of foetal calf serum (FCS) and eight parts by volume of the formulation to be tested (disinfectant) in 1.25 times the desired concentration. Immediately after the exposure time had elapsed, the test mixture was diluted 1:100 with PBS containing 10% FCS in order to abolish the effect of the disinfectant by dilution. Each mixture was subsequently investigated as duplicate determination of HBsAg in a radioimmuno- assay (RIA) (Ausria II, Abbott Lab., North Chicago, 111., USA) and the average radioactivity was calculated.
The following controls were also included. A test mixture containing double-distilled water in place of the disinfectant was investigated for HBsAg after the longest of the tested exposure times. This mixture, which was also carried out with serum albumin and FCS, represented the initial values for calculating the increase in HBsAg. A test mixture without added virus
(disinfectant controls) and a test mixture exclusively with the diluent also took place in order to identify in this way, by comparison of the values, a nonspecificity due to disinfectant present (see attached key) .
Positive and negative controls from the manufacturer' s test kit were also included.
Then, in accordance with the method described by G. Frδsner, G. Jentsch, H. Uthermann in Zbl . Bakt. Hyg. I. Abt. Orig. B 176, 1, (1982) "Zerstδrung der Antigenitat und Beeinflussung der immunochemischen Reaktivitat von Antigenen des Hepatitis-B-Virus (HbsAg, HbcAg and HbeAg) durch Desinfektionsmittel im Prϋfmodell", complete inactivation of HBsAg was assumed if the radioactivity (cpm) after exposure to the disinfectant was less than 2.1 times the radioactivity (cpm) of the test mixture without added virus. The disinfectant in these test mixtures was mixed with double-distilled water, serum albumin or FCS, and was then diluted 1:100 in PBS with 10% FCS in accordance with the description above. Explanation of the mixtures :
HBsAG controls
I serum + double-distilled water + double- distilled water
II serum + 2% albumin + double-distilled water
III serum + FCS + double-distilled water
Disinfectant controls
I double-distilled water + double-distilled water + disinfectant
II double-distilled water + 2% albumin + disinfectant
III double-distilled water + FCS + disinfectant
Diluent control
10% FCS in PBS
Inactivation mixture
I serum + double-distilled water + disinfectant
II serum + 2% albumin + disinfectant
III serum + FCS + disinfectant
Investigation of the foaming power of formulations
The following tests serve to assess the foaming power of a formulation solution (disinfectant solution) .
A 100 ml measuring cylinder (high form with graduation and lettering) with a fitting stopper and a stop-clock are required. For the investigation, 30 ml of the formulation solution to be tested are introduced into the measuring cylinder, avoiding foaming as far as possible (if foam has formed on introduction of the formulation solution, the test is not carried out until - li the foam has disappeared.) The stopper is then put on. The measuring cylinder is shaken vigorously ten times and then put down, starting the stop-clock simultaneously. The height of the foam in the measuring cylinder (volume of the sample including foam) is then read off after predetermined times. The results of the investigation are recorded, stating the sample temperature .
Example 1
Formulation IB was investigated as 1.0% strength, 2.0% strength and 3.0% strength solution in the inactivation tests. The exposure times were 5, 15 and 30 minutes. The results are shown in Tables 1-3 below.
Table 1: Hepatitis B-inactivating properties of formulation IB (1.0%) in the antigen assay. The cpm are shown.
Figure imgf000012_0001
n.d. = not done
Diluent control: 186.0
Lower limit of detection of HBsAg I 262.5 in the individual mixtures (cut off) II 275.1
III 279.3 Table 2: Hepatitis B-inactivating properties of formulation IB (2.0%) in the antigen assay. The cpm are shown.
Figure imgf000013_0001
Diluent control: 186.0
Lower limit of detection of HBsAg I 245.7 in the individual mixtures (cut off) II 241.5
III 254.1
Table 3: Hepatitis B-inactivating properties of formulation IB (3.0%) in the antigen assay. The cpm are shown.
Figure imgf000013_0002
Diluent control: 186.0
Lower limit of detection of HBsAg I 254.1 in the individual mixtures (cut off) II 231.0
III 266.7 Evaluation of example 1
No interference with the detection method by the presence of disinfectant was evident because the results for the disinfectant controls were in the region of the value for the diluent (cpm = 186.0).
Formulation IB showed a strong effect on the immunological reactivity of HBsAg. However, in the investigation of the 1% strength solution, counts above the lower limit of detection were not seen until after an exposure time of 30 minutes (see Table 1) . The 2% strength dilution of the disinfectant in particular showed HBV activity (see Table 2) . It can be stated as a result that a 2% strength solution of formulation IB can be employed for HBV inactivation on use for 15 minutes as surface disinfectant.
According to the Deutsches Arzteblatt 84, No. 18, page B874 of 30 April 1987, the committee on questions of viral disinfection in human medicine of the German association for the control of viral diseases (DVV) and of the German health agency (BGA) have summed up that all precautionary measures against transmission of hepatitis B are also HIV-preventive .
Exemplary formulation IB shows that the activity of quaternary ammonium compounds against HBV is increased through use of 1% by weight fatty acid salt (sodium oleate) . It was also possible to reduce the total amount of active ingredients.
Example 2
Formulations 2A and 2B were tested for their HBV activity correspondingly. The results are shown in Table 4 below. Table 4: HBV activity of formulations based on quaternary ammonium compound
Figure imgf000015_0001
Example 3
The procedure was as in Examples 1 and 2, but the suspensions were heated to 55°C.
Table 5: HBV activity of formulations based on alkylamine (at 55°C)
Figure imgf000015_0002
It is possible through the use of sodium oleate both to reduce foaming and to improve the action on HBV.
Example 4 (reduction in foaming)
Formulations based on quaternary ammonium compound
Figure imgf000016_0001
The formulations solutions were 2% strength solutions in tap water at 22°C.
Table 6: Foaming of various disinfectant solutions
Figure imgf000016_0002
Result :
Formulation 4A showed foam suppression Formulation 4B showed foam suppression Formulation 4C showed no foam suppression

Claims

Claims
1. Water-based disinfectant which comprises
a) at least one alkylamine and/or at least one quaternary ammonium compound and
b) at least one fatty acid RCOOH and/or salt thereof, where R is a group having at least 7 carbon atoms.
2. Disinfectant according to Claim 1, characterized in that the quaternary ammonium compound is benzalkonium chloride, didecyldimethylammonium chloride or dioctyldimethylammonium chloride.
3. Disinfectant according to Claim 1 or Claim 2, characterized in that the alkylamine is bis (3-aminopropyl) octylamine, aminopropyldodecylamine, dodecylpropylenediamine, coconut fatty amine 2E0 or dimethyl coconut fatty amine.
4. Disinfectant according to any of the preceding claims, characterized in that group R is saturated or unsaturated, unbranched or branched C9- to C25~alkyl, preferably Cn- to C23-alkyl, in particular monounsaturated Cι3- to C2ι-alkyl, with oleic acid being particularly preferred as fatty acid.
5. Disinfectant according to any of the preceding claims, characterized in that the salt of the fatty acid is alkali metal or ammonium salt, preferably sodium salt, in particular sodium oleate.
6. Disinfectant according to any one of the preceding claims, characterized in that the disinfectant comprises from 1 to 40% by weight, preferably 3 to 25% by weight, in particular 5 to 20% by weight, of component a), based on the disinfectant.
7. Disinfectant according to any of the preceding claims, characterized in that the disinfectant comprises from 0.05 to 5% by weight, preferably 0.1 to 3% by weight, in particular 0.5 to 2% by weight, of component b) , stated as free acid RCOOH, based on the disinfectant .
8. Disinfectant according to claim 7, characterized in that it comprises
a) 5 to 20% by weight of quaternary ammonium compound and/or alkylamine, in particular dioctyldimethylammonium chloride, and b) 0.5 to 2% by weight of sodium oleate.
9. Disinfectant according to any of the preceding claims, characterized in that it additionally comprises one or more further substances selected from nonionic surfactants, short-chain organic acids selected from the group consisting of lactic acid, glycolic acid, citric acid, malic acid, succinic acid, tartaric acid, formic acid, acetic acid, propionic acid or salts thereof, corrosion inhibitors, perfume, dye and alcohols.
10. Disinfectant according to Claim 8 or 9 in the form of a surface disinfectant, characterized in that it comprises
a) 5 to 10% by weight, preferably 6 to 9% by weight, of quaternary ammonium compound, in particular dioctyldimethylammonium chloride, b) 0.3 to 3% by weight, preferably 0.8 to 1.6% by weight, of sodium oleate and c) 0.2 to 1.0, preferably 0.3 to 0.7% by weight of nonionic surfactant.
11. Disinfectant according to Claim 8 or 9 in the form of an instrument disinfectant for thermochemical treatment, characterized in that it comprises
a) 10 to 20% by weight, preferably 13 to 17% by weight, of quaternary ammonium compound, in particular dioctyldimethylammonium chloride,
b) 2 to 7% by weight, preferably 3 to 5% by weight, of sodium oleate,
c) 1 to 3 % by weight, preferably 1.5 to 2.5% by weight, of nonionic surfactant and
d) 10 to 50% by weight, preferably 20 to 40% by weight, of alcohol.
12. Use of a disinfectant according to any of the preceding claims for inactivating hepatitis B virus.
13. Use according to Claim 12, characterized in that the disinfectant is employed in a method for disinfecting surfaces or instruments.
14. Use according to Claim 12 or 13, characterized in that the disinfectant is formulated with water to a ready-to-use solution which comprises 0.3 to 10% by weight, preferably 0.5 to 5% by weight, in particular 1 to 3% by weight, of the disinfectant.
15. Use according to Claim 13 or 14, characterized in that the use takes place in a method for disinfecting instruments which comprises the following steps:
a) where appropriate precleaning with cold water,
b) cleaning at 55 to 60°C with a neutral cleaner, c) thermochemical disinfection at 55 to 60°C and an exposure time of from 1 to 20 minutes to a disinfectant according to any of Claims 1 to
11,
d) rinsing with cold water and
e) drying.
PCT/IB2003/001137 2002-05-29 2003-03-28 Disinfectant with activity against hepatitis b virus WO2003099006A1 (en)

Priority Applications (5)

Application Number Priority Date Filing Date Title
AU2003215806A AU2003215806A1 (en) 2002-05-29 2003-03-28 Disinfectant with activity against hepatitis b virus
EP03755238.7A EP1511381B1 (en) 2002-05-29 2003-03-28 Disinfectant with activity against hepatitis b virus
JP2004506543A JP4505323B2 (en) 2002-05-29 2003-03-28 Bactericides having activity against hepatitis B virus
ES03755238T ES2432545T3 (en) 2002-05-29 2003-03-28 Disinfectant with hepatitis B virus activation
US10/515,258 US20050215639A1 (en) 2002-05-29 2003-03-28 Disinfectant with activity against hepatitis b virus

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
DE10223934A DE10223934B4 (en) 2002-05-29 2002-05-29 Use of a disinfectant to inactivate hepatitis B virus
DE10223934.7 2002-05-29

Publications (1)

Publication Number Publication Date
WO2003099006A1 true WO2003099006A1 (en) 2003-12-04

Family

ID=29557389

Family Applications (1)

Application Number Title Priority Date Filing Date
PCT/IB2003/001137 WO2003099006A1 (en) 2002-05-29 2003-03-28 Disinfectant with activity against hepatitis b virus

Country Status (7)

Country Link
US (1) US20050215639A1 (en)
EP (1) EP1511381B1 (en)
JP (3) JP4505323B2 (en)
AU (1) AU2003215806A1 (en)
DE (1) DE10223934B4 (en)
ES (1) ES2432545T3 (en)
WO (1) WO2003099006A1 (en)

Cited By (8)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
EP1627646A1 (en) * 2004-08-16 2006-02-22 Bode Chemie GmbH & Co. Cleaning and disinfecting agent for medical instruments with improved effectiveness against Hepatitis B Virus
FR2899061A1 (en) * 2006-03-31 2007-10-05 Cid Lines Nv Hygienic, cosmetic and/or disinfectant composition, useful for treating and/or washing of teats and/or udder of mammals e.g. cow, comprises a fatty acid as repellent and/or insecticide composition against arthropods e.g. flies
WO2010119966A1 (en) * 2009-04-17 2010-10-21 シャボン玉石けん株式会社 Antiviral agent and cleanser
EP2392211A1 (en) * 2010-06-02 2011-12-07 Cognis IP Management GmbH Biocide compositions comprising quaternary carboxylic acid alkyl ammonium salts
CN108026025A (en) * 2015-09-17 2018-05-11 艺康美国股份有限公司 The method for preparing triamine solid
EP3381284A1 (en) * 2015-09-17 2018-10-03 Ecolab USA Inc. Triamine solidification using diacids
EP3542628A1 (en) * 2018-03-22 2019-09-25 Chemische Fabrik Dr. Weigert GmbH & Co. KG Disinfectant and use of n,n-bis(3-aminopropyl) alkylamine in disinfectant
EP3445169A4 (en) * 2016-04-21 2019-09-25 OMS Investments, Inc. Compositions of a quaternary ammonium compound with a monocarboxylic fatty acid

Families Citing this family (17)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
DE10223934B4 (en) * 2002-05-29 2009-04-09 Schülke & Mayr GmbH Use of a disinfectant to inactivate hepatitis B virus
DE102006006765A1 (en) * 2006-02-13 2007-08-16 Schülke & Mayr GmbH Alkaline disinfectant and cleaner with improved cleaning performance
US7962718B2 (en) * 2007-10-12 2011-06-14 Freescale Semiconductor, Inc. Methods for performing extended table lookups using SIMD vector permutation instructions that support out-of-range index values
US8700884B2 (en) * 2007-10-12 2014-04-15 Freescale Semiconductor, Inc. Single-instruction multiple-data vector permutation instruction and method for performing table lookups for in-range index values and determining constant values for out-of-range index values
DE102007058061A1 (en) 2007-11-30 2009-06-04 Justus-Liebig-Universität Giessen Test system for determining the effectiveness of infection-eliminating agents or measures against hepatitis B virus comprises tupaia hepatocytes and human hepatitis virus
US9125911B2 (en) 2013-03-14 2015-09-08 Quadex Pharmaceuticals, Llc Combined systemic and topical treatment of disordered tissues
US9463180B2 (en) 2013-03-14 2016-10-11 Quadex Pharmaceuticals, Llc Treatment of molluscum contagiosum
US9549930B2 (en) 2013-03-14 2017-01-24 Quadex Pharmaceuticals, Llc Combined systemic and topical treatment of disordered and/or prodromal stage tissue
JP6154275B2 (en) * 2013-09-27 2017-06-28 株式会社Lixil Antibacterial / antiviral coating and method for forming antibacterial / antiviral coating
JP6654353B2 (en) * 2015-03-26 2020-02-26 株式会社Adeka Hard surface cleaning composition and method for cleaning hard surface
JP6603495B2 (en) 2015-07-01 2019-11-06 株式会社Lixil Antibacterial and antiviral coating agent
JP2017122061A (en) * 2016-01-06 2017-07-13 花王株式会社 Liquid disinfectant composition
JP7491548B2 (en) 2020-03-17 2024-05-28 株式会社ニイタカ Composition for a former, a former containing said composition for a former, a disinfection method using said composition for a former, and a cleaning method using said composition for a former
CN115038333A (en) * 2020-03-23 2022-09-09 埃科莱布美国股份有限公司 Novel 2 in 1 germicidal rinse aid compositions using amine based surfactants in warewashing
WO2022038955A1 (en) * 2020-08-20 2022-02-24 大日本除蟲菊株式会社 Virus inactivating agent composition, virus inactivation efficacy enhancing method, and virus inactivation method
DE102021002147A1 (en) 2021-04-23 2022-10-27 Thomas Meneghini Disinfectants and their use
WO2022223573A1 (en) 2021-04-23 2022-10-27 Thomas Meneghini Disinfectant and use thereof

Citations (12)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US4110504A (en) * 1975-04-25 1978-08-29 Anthony B. Askew Self-sanitizing carpet construction composition
GB2103089A (en) 1981-07-20 1983-02-16 Kimberly Clark Co Use of carboxylic acids as virucides
EP0147976A1 (en) * 1983-12-13 1985-07-10 Hickson's Timber Products Limited Biocidal amine salts
US4585795A (en) * 1982-03-19 1986-04-29 Kymi Kymmeno Oy Control agent for protecting timber against fungi employing a mixture of an organic carboxylic acid salt and quaternary ammonium salt
AT382310B (en) 1985-09-30 1987-02-10 Horst Felsch Method for decalcifying, disinfecting and cleaning mouth rinse devices, etc
EP0339957A2 (en) * 1988-04-28 1989-11-02 Dow Corning Corporation A synergistic antimicrobial composition
EP0505763A1 (en) 1991-03-27 1992-09-30 Fresenius AG Aqueous disinfectant, its use for inactivation of Hepatitus-B virus, bacterial spores and Legionella pneumophila, and method of disinfection
EP0520785A1 (en) * 1991-06-28 1992-12-30 Finnish Chemicals Oy A biocide composition
JPH08259444A (en) * 1995-03-24 1996-10-08 Earth Chem Corp Ltd Enhancer for bactericidal efficacy and composition for oral cavity comprising the same blended therein
WO1998003066A1 (en) * 1996-07-19 1998-01-29 Kemira Chemicals Oy An antimicrobial composition, a method for the preparation of same
US6054139A (en) * 1996-05-10 2000-04-25 Diversey Lever Inc. Cleaning and/or disinfecting composition
EP1195091A1 (en) * 2000-08-19 2002-04-10 Bode Chemie GmbH & Co. Disinfectant concentrate and its use for automated instrument disinfection

Family Cites Families (16)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
CH548777A (en) * 1969-09-17 1974-05-15 Good Johann Anton DISINFECTANT.
JPS56123906A (en) * 1980-03-04 1981-09-29 Nippon Synthetic Chem Ind Co Ltd:The Antibacterial, antimold composition
DE3117792C2 (en) * 1981-05-06 1990-08-23 Schülke & Mayr GmbH, 2000 Norderstedt The use of an aqueous solution of alcohols, phenols and surfactants as a virucidal agent
GB8625103D0 (en) * 1986-10-20 1986-11-26 Unilever Plc Disinfectant compositions
JPH02225404A (en) * 1989-02-27 1990-09-07 Shiseido Co Ltd Antibacterial composition
JPH0482803A (en) * 1990-06-20 1992-03-16 Nippon Shokubai Co Ltd Substrate for sustained releasing chemical in water
US5665307A (en) * 1991-03-27 1997-09-09 Fresenius Ag Aqueous disinfecting agent
JP2958617B2 (en) * 1995-09-08 1999-10-06 三洋化成工業株式会社 Hypoallergenic antimicrobial composition
DE19733684A1 (en) * 1997-08-04 1999-02-11 Henkel Kgaa Preservative system for personal care products
DE19742222A1 (en) * 1997-09-24 1999-04-01 Henkel Kgaa Use of quaternary carboxylic acid alkanolamine ester salts as microbicidal active ingredients
JP3091841B2 (en) * 1997-12-02 2000-09-25 三洋化成工業株式会社 Antimicrobial detergent composition
US6106854A (en) * 1998-03-25 2000-08-22 Belfer; William A. Disinfectant composition for infectious water and surface contaminations
PL201886B1 (en) * 1999-06-25 2009-05-29 Lonza Ag Disinfectants
JP4558955B2 (en) * 2001-01-18 2010-10-06 株式会社Adeka Bactericidal composition
US6395698B1 (en) * 2001-06-11 2002-05-28 Mason Chemical Company Corrosion resistant sanitizing/disinfecting cleaning and wood preservative formulation
DE10223934B4 (en) * 2002-05-29 2009-04-09 Schülke & Mayr GmbH Use of a disinfectant to inactivate hepatitis B virus

Patent Citations (12)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US4110504A (en) * 1975-04-25 1978-08-29 Anthony B. Askew Self-sanitizing carpet construction composition
GB2103089A (en) 1981-07-20 1983-02-16 Kimberly Clark Co Use of carboxylic acids as virucides
US4585795A (en) * 1982-03-19 1986-04-29 Kymi Kymmeno Oy Control agent for protecting timber against fungi employing a mixture of an organic carboxylic acid salt and quaternary ammonium salt
EP0147976A1 (en) * 1983-12-13 1985-07-10 Hickson's Timber Products Limited Biocidal amine salts
AT382310B (en) 1985-09-30 1987-02-10 Horst Felsch Method for decalcifying, disinfecting and cleaning mouth rinse devices, etc
EP0339957A2 (en) * 1988-04-28 1989-11-02 Dow Corning Corporation A synergistic antimicrobial composition
EP0505763A1 (en) 1991-03-27 1992-09-30 Fresenius AG Aqueous disinfectant, its use for inactivation of Hepatitus-B virus, bacterial spores and Legionella pneumophila, and method of disinfection
EP0520785A1 (en) * 1991-06-28 1992-12-30 Finnish Chemicals Oy A biocide composition
JPH08259444A (en) * 1995-03-24 1996-10-08 Earth Chem Corp Ltd Enhancer for bactericidal efficacy and composition for oral cavity comprising the same blended therein
US6054139A (en) * 1996-05-10 2000-04-25 Diversey Lever Inc. Cleaning and/or disinfecting composition
WO1998003066A1 (en) * 1996-07-19 1998-01-29 Kemira Chemicals Oy An antimicrobial composition, a method for the preparation of same
EP1195091A1 (en) * 2000-08-19 2002-04-10 Bode Chemie GmbH & Co. Disinfectant concentrate and its use for automated instrument disinfection

Non-Patent Citations (4)

* Cited by examiner, † Cited by third party
Title
DATABASE WPI Section Ch Week 199650, Derwent World Patents Index; Class B05, AN 1996-502627, XP002244995 *
HYGIENE + MEDIZIN, vol. 14, 1989, pages 69
TIERARZTIICHE UMSCHAU, vol. 43, 1988, pages 646
WALLHÂUSER: "Praxis der Sterilisation", 1988, HENKEL CHEMISCHE BIBLIOTHEK, pages: 75

Cited By (20)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
EP1627646A1 (en) * 2004-08-16 2006-02-22 Bode Chemie GmbH & Co. Cleaning and disinfecting agent for medical instruments with improved effectiveness against Hepatitis B Virus
FR2899061A1 (en) * 2006-03-31 2007-10-05 Cid Lines Nv Hygienic, cosmetic and/or disinfectant composition, useful for treating and/or washing of teats and/or udder of mammals e.g. cow, comprises a fatty acid as repellent and/or insecticide composition against arthropods e.g. flies
EP1842425A1 (en) 2006-03-31 2007-10-10 Cid Lines N.V. Hygienic and/or cosmetic and/or disinfectant composition containing at least one anti-parasite and/or insect repellent agent
WO2010119966A1 (en) * 2009-04-17 2010-10-21 シャボン玉石けん株式会社 Antiviral agent and cleanser
EP2392211A1 (en) * 2010-06-02 2011-12-07 Cognis IP Management GmbH Biocide compositions comprising quaternary carboxylic acid alkyl ammonium salts
WO2011151042A3 (en) * 2010-06-02 2012-08-23 Cognis Ip Management Gmbh Biocide compositions comprising quaternary carboxylic acid alkyl ammonium salts
EP3350155A4 (en) * 2015-09-17 2019-05-08 Ecolab USA Inc. Triamine solidification using diacids
US10440950B2 (en) 2015-09-17 2019-10-15 Ecolab Usa Inc. Methods of making triamine solids
EP3381284A1 (en) * 2015-09-17 2018-10-03 Ecolab USA Inc. Triamine solidification using diacids
EP3350156A4 (en) * 2015-09-17 2019-05-01 Ecolab USA Inc. Methods of making triamine solids
CN108026025A (en) * 2015-09-17 2018-05-11 艺康美国股份有限公司 The method for preparing triamine solid
US11730167B2 (en) 2015-09-17 2023-08-22 Ecolab Usa Inc. Triamine solidification using diacids
US11051512B2 (en) 2015-09-17 2021-07-06 Ecolab Usa Inc. Triamine solidification using diacids
EP3381285A1 (en) * 2015-09-17 2018-10-03 Ecolab USA Inc. Methods of making triamine solids
US10463041B2 (en) 2015-09-17 2019-11-05 Ecolab Usa Inc. Triamine solidification using diacids
CN108026025B (en) * 2015-09-17 2021-02-02 艺康美国股份有限公司 Process for preparing triamine solids
EP3445169A4 (en) * 2016-04-21 2019-09-25 OMS Investments, Inc. Compositions of a quaternary ammonium compound with a monocarboxylic fatty acid
AU2017252461B2 (en) * 2016-04-21 2021-09-02 Oms Investments, Inc. Compositions of a quaternary ammonium compound with a monocarboxylic fatty acid
AU2021277622B2 (en) * 2016-04-21 2024-02-01 Oms Investments, Inc. Compositions of a quaternary ammonium compound with a monocarboxylic fatty acid
EP3542628A1 (en) * 2018-03-22 2019-09-25 Chemische Fabrik Dr. Weigert GmbH & Co. KG Disinfectant and use of n,n-bis(3-aminopropyl) alkylamine in disinfectant

Also Published As

Publication number Publication date
EP1511381A1 (en) 2005-03-09
DE10223934B4 (en) 2009-04-09
JP4505323B2 (en) 2010-07-21
US20050215639A1 (en) 2005-09-29
AU2003215806A1 (en) 2003-12-12
EP1511381B1 (en) 2013-08-21
JP2013253081A (en) 2013-12-19
DE10223934A1 (en) 2003-12-18
ES2432545T3 (en) 2013-12-04
JP5345576B2 (en) 2013-11-20
JP2005527609A (en) 2005-09-15
JP2010195782A (en) 2010-09-09
JP5661864B2 (en) 2015-01-28

Similar Documents

Publication Publication Date Title
JP5661864B2 (en) Bactericides having activity against hepatitis B virus
JP2693149B2 (en) disinfectant
US4661523A (en) Disinfectant solutions having improved corrosion properties
EP2575444B1 (en) Dilutable biocidal compositions and methods of use
US5185145A (en) Disinfectant concentrate and its use as a mycobactericide and viricide
US5284875A (en) Fortified quarternary ammonium compound with dual synergistic phenols
JPH02288808A (en) Sprayable surface disinfectant
US7481973B2 (en) Composition and process for chemical and thermal disinfection
MXPA02000085A (en) Disinfectants.
EP0609106B1 (en) A glutaraldehyde composition
JP4579412B2 (en) Mycobacterium tuberculosis disinfectant
JP4772274B2 (en) Liquid composition and method for reducing odor of inanimate materials
US5674829A (en) Stable aqueous glutaraldehyde solutions containing sodium acetate and a nonionic detergent
US20050096227A1 (en) Herbicidal composition and use
CA3059326A1 (en) Composition for disinfecting surfaces containing tuberculosis causing bacteria
RU2173337C1 (en) Disinfecting-detergent solution
RU2366175C1 (en) Disinfectant
JP2004313792A (en) Method for chemical/thermal disinfection
CN116964183A (en) Liquid disinfectant composition and use thereof
KR19990053084A (en) Aromatic fungicide composition for humidifier
JP3609773B2 (en) Cultured laver treatment agent, cultured laver treatment solution, and cultured laver treatment method

Legal Events

Date Code Title Description
AK Designated states

Kind code of ref document: A1

Designated state(s): AE AG AL AM AT AU AZ BA BB BG BR BY BZ CA CH CN CO CR CU CZ DE DK DM DZ EC EE ES FI GB GD GE GH GM HR HU ID IL IN IS JP KE KG KP KR KZ LC LK LR LS LT LU LV MA MD MG MK MN MW MX MZ NO NZ OM PH PL PT RO RU SD SE SG SK SL TJ TM TN TR TT TZ UA UG US UZ VN YU ZA ZM ZW

AL Designated countries for regional patents

Kind code of ref document: A1

Designated state(s): GH GM KE LS MW MZ SD SL SZ TZ UG ZM ZW AM AZ BY KG KZ MD RU TJ TM AT BE BG CH CY CZ DE DK EE ES FI FR GB GR HU IE IT LU MC NL PT RO SE SI SK TR BF BJ CF CG CI CM GA GN GQ GW ML MR NE SN TD TG

121 Ep: the epo has been informed by wipo that ep was designated in this application
WWE Wipo information: entry into national phase

Ref document number: 2003755238

Country of ref document: EP

Ref document number: 10515258

Country of ref document: US

WWE Wipo information: entry into national phase

Ref document number: 2004506543

Country of ref document: JP

WWP Wipo information: published in national office

Ref document number: 2003755238

Country of ref document: EP